查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604496

精准治疗人工智慧（AI）市场：未来预测（2024-2029）

Artificial Intelligence (AI) In Precision Therapies Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

精准医疗人工智慧（AI）市场预计将以27.56%的复合年增长率成长，2029年市场规模达到75.06亿美元，2024年市场规模达到22.23亿美元。

精准医疗人工智慧市场是一种独特的颠覆性方法，正在彻底改变个人化医疗和患者照护。个体化医疗根据每位患者的遗传、生活方式和疾病特征量身定制治疗方案，旨在实现最佳效果，同时最大限度地减少副作用。该领域正在迅速利用人工智慧技术来探索潜在的生物标记、药物作用目标、治疗方案、低效的资料管理、患者分层等。正确的人工智慧技术可以处理大量患者记录、遗传资讯和临床试验结果，帮助医疗保健提供者针对患者进行药物和治疗。

精准医疗的人工智慧市场前景广阔，因为它有潜力重塑医疗领域，实现更有效、以病人为中心的照护。

精准治疗的人工智慧 (AI) 市场驱动力

  • 个人化医疗和精准医疗的不断成长趋势正在推动精准医疗人工智慧 (AI) 市场的成长。

随着个人化医疗和精准医疗的变革，人工智慧技术越来越多地被应用于精准治疗。这些变化凸显了针对具有不同遗传倾向、生活方式和疾病特征的不同患者客製化医疗干预措施的重要性。新技术和分子生物学已经能够识别各种生物标记和治疗靶点，使治疗更加精确和特异性。人工智慧对于透过基因组学、临床资料和即时患者资讯等广泛资料集集来预测治疗反应和疾病结果至关重要。人们越来越重视个人化医疗和精准医疗的有效性，以促进积极的患者治疗结果，从而增加了基于人工智慧的系统在精准医疗中的采用。

精准治疗的人工智慧 (AI) 市场：地理视角

  • 北美在预测期内将经历指数级增长

美国在精准医疗和治疗领域人工智慧技术的研究、开发和使用方面处于主导。北美的领先优势并不令人意外，因为其医疗设施完善、人工智慧资金水平高、以及大型製药和生物技术公司。此外，该地区个人化和精准医疗的整体趋势正在塑造人工智慧解决方案的市场，以改善治疗和患者的治疗结果。人工智慧技术的进步必将确保北美继续占据精准医疗人工智慧市场的最大份额。

为什么要购买这份报告？

  • 富有洞察力的分析：获得涵盖主要和新兴地区的深入市场洞察，重点关注客户细分、政府政策和社会经济因素、消费者偏好、行业明智以及其他子区隔。
  • 竞争格局：了解世界主要企业采取的策略策略，并了解透过正确的策略渗透市场的潜力。
  • 市场驱动因素和未来趋势：探索动态因素和关键市场趋势以及它们将如何影响未来市场发展。
  • 可行的建议：利用洞察力做出策略决策，以在动态环境中发现新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业有用且具有成本效益。

它有什么用？

产业与市场考量、商机评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

分析范围

  • 历史资料与预测（2022-2029）
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 收益成长率与预测分析：按细分市场/地区（按国家）
  • 公司概况（策略、产品、财务资讯、主要趋势等）

目录

第一章简介

  • 市场概况
  • 市场定义
  • 分析范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章 分析方法

  • 分析设计
  • 分析过程

第三章执行摘要

  • 主要发现
  • CXO观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章精准治疗的人工智慧（AI）市场：按治疗类型

  • 介绍
  • 个人化医疗
  • 标靶治疗
  • 基因治疗
  • 细胞疗法
  • 免疫疗法
  • 其他的

第六章精准治疗人工智慧（AI）市场：依应用分类

  • 介绍
  • 瘤
  • 神经系统疾病
  • 心臟病
  • 感染疾病
  • 罕见疾病
  • 自体免疫疾病
  • 其他的

第七章终端使用者产业精准治疗的人工智慧（AI）市场

  • 介绍
  • 医院/诊所
  • 製药和生物技术公司
  • 研究机构/学术中心
  • 其他的

第八章精准治疗的人工智慧（AI）市场：按地区

  • 介绍
  • 北美洲
    • 按治疗类型
    • 按用途
    • 按最终用户产业
    • 按国家/地区
  • 南美洲
    • 按治疗类型
    • 按用途
    • 按最终用户产业
    • 按国家/地区
  • 欧洲
    • 按治疗类型
    • 按用途
    • 按最终用户产业
    • 按国家/地区
  • 中东/非洲
    • 按治疗类型
    • 按用途
    • 按最终用户产业
    • 按国家/地区
  • 亚太地区
    • 按治疗类型
    • 按用途
    • 按最终用户产业
    • 按国家/地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 企业合併（M&A）、合约、业务合作
  • 竞争对手仪表板

第十章 公司简介

  • IBM Watson Health (IBM Corporation)
  • Google Health (Alphabet Inc.)
  • Tempus Labs, Inc.
  • Nvidia Corporation
  • Deep Genomics, Inc.
  • Microsoft Corporation
  • Owkin, Inc.
  • Benevolentai Ltd.
  • Recursion Pharmaceuticals, Inc.
  • Cloud Pharmaceuticals, Inc.
简介目录
Product Code: KSI061615866

Artificial intelligence (AI) in the precision therapies market is expected to grow at a CAGR of 27.56%, reaching a market size of US$7.506 billion in 2029 and US$2.223 billion in 2024.

AI in the precision therapies market is a unique and disruptive method that is revolutionizing personalized medicine and patient care. Custom-made medication aims to tailor medical treatments to individual patients' genetics, way of life, and disease characteristics to achieve the best results with the least side complications. Within this field, the application of AI technology has become much faster in exploring potential biomarkers, targets for drug action, options for treatment, and inefficient data management and stratification of patients. Suitable AI techniques can handle large volumes of patient records, genetic information, and outcomes from clinical trials, thus assisting healthcare providers in administering their patients with targeted medications and therapies.

The market of AI in precision therapies is considerably promising in that it could reshape the healthcare sector into more effective and patient-oriented therapies.

Artificial intelligence (AI) in the precision therapies market drivers?

  • Rising trends in personalized and precision medicine are increasing the Artificial Intelligence (AI) in precision therapies market growth.

AI technologies employed in precision therapies are rising due to changes in personalized and precision medicine. These changes stress the importance of customizing medical interventions to different patients who have varying genetic makeups, lifestyles, and disease characteristics. New technologies and molecular biology have made identifying various biomarkers and therapeutic targets possible, making treatment more accurate and specific. AI is pivotal in predicting treatment responses and disease outcomes through extensive datasets such as genomes, clinical data, and real-time patient information. The growing emphasis on the effectiveness of personalized or precision medicine in promoting positive patient outcomes has led to increased uptake of AI-based systems in precision therapeutics.

Artificial intelligence (AI) in the precision therapies market - geographical outlook

  • North America is witnessing exponential growth during the forecast period

The US has led the research, development, and use of AI technology in precision medicine and therapeutics. It is not surprising that North America leads due to its well-established healthcare facilities, high-level AI funding, and large-scale pharmaceutical and biotech companies. In addition, the region's general trend towards personalized medicine and precision healthcare has created a market for AI-infused solutions that enhance treatment and patient outcomes. Advances in AI technologies will ensure that North America remains the largest shareholder in AI in the precision therapies market.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2029
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Artificial Intelligence (AI) in precision therapies market is segmented and analyzed as follows:

By Therapy Type

  • Personalized Medicine
  • Targeted Therapies
  • Gene Therapies
  • Cell Therapies
  • Immunotherapies
  • Others

By Application

  • Oncology
  • Neurology
  • Cardiology
  • Infectious Diseases
  • Rare Diseases
  • Autoimmune Diseases
  • Others

By End-User Industry

  • Hospitals And Clinics
  • Pharmaceutical And Biotechnology Companies
  • Research Institutes And Academic Centers
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. ARTIFICIAL INTELLIGENCE (AI) IN PRECISION THERAPIES MARKET BY THERAPY TYPE

  • 5.1. Introduction
  • 5.2. Personalized Medicine
  • 5.3. Targeted Therapies
  • 5.4. Gene Therapies
  • 5.5. Cell Therapies
  • 5.6. Immunotherapies
  • 5.7. Others

6. ARTIFICIAL INTELLIGENCE (AI) IN PRECISION THERAPIES MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Oncology
  • 6.3. Neurology
  • 6.4. Cardiology
  • 6.5. Infectious Diseases
  • 6.6. Rare Diseases
  • 6.7. Autoimmune Diseases
  • 6.8. Others

7. ARTIFICIAL INTELLIGENCE (AI) IN PRECISION THERAPIES MARKET BY END-USER INDUSTRY

  • 7.1. Introduction
  • 7.2. Hospitals And Clinics
  • 7.3. Pharmaceutical And Biotechnology Companies
  • 7.4. Research Institutes And Academic Centers
  • 7.5. Others

8. ARTIFICIAL INTELLIGENCE (AI) IN PRECISION THERAPIES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Therapy Type
    • 8.2.2. By Application
    • 8.2.3. BY End-User Industry
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Therapy Type
    • 8.3.2. By Application
    • 8.3.3. BY End-User Industry
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Therapy Type
    • 8.4.2. By Application
    • 8.4.3. BY End-User Industry
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Italy
      • 8.4.4.5. Spain
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Therapy Type
    • 8.5.2. By Application
    • 8.5.3. BY End-User Industry
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Therapy Type
    • 8.6.2. By Application
    • 8.6.3. BY End-User Industry
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Thailand
      • 8.6.4.7. Indonesia
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. IBM Watson Health (IBM Corporation)
  • 10.2. Google Health (Alphabet Inc.)
  • 10.3. Tempus Labs, Inc.
  • 10.4. Nvidia Corporation
  • 10.5. Deep Genomics, Inc.
  • 10.6. Microsoft Corporation
  • 10.7. Owkin, Inc.
  • 10.8. Benevolentai Ltd.
  • 10.9. Recursion Pharmaceuticals, Inc.
  • 10.10. Cloud Pharmaceuticals, Inc.